Results The results of this study showed that mice treated with Agens 128 exhibited a significant reduction in inflammatory markers compared to the placebo group. Specifically, levels of pro-inflammatory cytokines, such as interleukin-6 and tumor necrosis factor-alpha, were significantly lower in the Agens 128-treated group. Furthermore, the mice treated with Agens 128 showed improved behavior and physical condition compared to the placebo group, indicating that the compound had minimal side ef...